Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
| ▸ | HTR2C | P28335 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | TST | Q16762 | 2/20 | 0.83 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.83 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.83 |
| ▸ | MEN1 | O00255 | 7/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.74 |
| ▸ | USP2 | O75604 | 4/20 | 0.74 |
| ▸ | HTT | P42858 | 4/20 | 0.74 |
| ▸ | HAT1 | O14929 | 4/20 | 0.74 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.74 |
| ▸ | RECQL | P46063 | 3/20 | 0.74 |
| ▸ | CASP7 | P55210 | 3/20 | 0.74 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | CASP1 | P29466 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin 5'-Phosphate SCHEMBL190079 | 1.00 | ESR1 (1.00) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL41133 | 1.00 | ESR1 (1.00) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL1532396 | 1.00 | ESR1 (1.00) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL6681480 | 0.99 | ESR1 (0.98) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL29592831 | 0.96 | ESR1 (0.93) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL14571231 | 0.94 | ESR1 (0.89) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL19864293 | 0.94 | ESR1 (0.88) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL11995383 | 0.94 | ESR1 (0.88) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL3402467 | 0.93 | ESR1 (0.86) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin 5'-Phosphate SCHEMBL8656633 | 0.92 | TST (0.98) | ESR1NR3C1ADRB2HTR2CADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116120585-B | Preparation method for preparing amino acid photocatalytic decarboxylation oxidation product by means of photocatalyst | 北京化工大学 | 2023-11-14 | — | — | CN | claimed |
| CN-116120585-A | Preparation method for preparing amino acid photocatalytic decarboxylation oxidation product by means of photocatalyst | 北京化工大学 | 2023-05-16 | — | — | CN | claimed |
| EP-2179006-B1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | KARLSRUHER INST TECHNOLOGIE (DE) | 2020-07-01 | — | — | EP | claimed |
| US-8480928-B2 | Inorganic-organic composite luminophore | KARLSRUHER INSTITUT FUR TECHNOLOGIE (KIT) (DE) | 2013-07-09 | — | — | US | claimed |
| EP-2560634-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | Piramal Enterprises Limited (IN) | 2013-02-27 | — | — | EP | claimed |
| WO-2011132171-A1 | NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | WO | claimed |
| US-20110263526-A1 | Nitric Oxide Releasing Prodrugs of Therapeutic Agents | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2011-10-27 | — | — | US | claimed |
| US-20110198538-A1 | INORGANIC-ORGANIC COMPOSITE LUMINOPHORE | Karlsruher Institut for Technologie (KIT) (DE) | 2011-08-18 | — | — | US | claimed |
| US-7776364-B2 | Non-surgical method for treating cataracts in mammals including man | ADVANCED SCIENTIFIC, LLC (US) | 2010-08-17 | — | — | US | claimed |
| US-20070224294-A1 | Novel non-surgical method for treating cataracts in mammals including man | ADVANCED SCIENTIFIC | 2007-09-27 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-12515213-B2 | Membranes and their uses | FUJIFILM MANUFACTURING EUROPE B.V. (NL) | 2026-01-06 | — | — | US | disclosed |
| EP-4615577-A1 | METHODS OF TREATING EYE PAIN AND EYE DISORDERS | Aisa Pharma, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| EP-3441049-B1 | OPHTHALMIC TREATMENT DEVICE | EPION THERAPEUTICS INC (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-4558546-A1 | PHOTOCURABLE HYDROGEL COMPOSITIONS | Tympanogen, Inc. (US) | 2025-05-28 | — | — | EP | disclosed |
| US-4668630-A | COMPLEXING LACTIC DEHYDROGENASE WITH DIPOTASSIUM OXALATE | BECKMAN INSTRUMENTS, INC. (US) | 1987-05-26 | — | — | US | disclosed |
| EP-0027631-B1 | FLAVIN ADENINE DINUCLEOTIDE-LABELED PROTEIN AND POLYPEPTIDE CONJUGATES | MILES LABORATORIES, INC. (US) | 1982-05-05 | — | — | EP | disclosed |
| EP-0027631-A1 | Flavin adenine dinucleotide-labeled protein and polypeptide conjugates | MILES LABORATORIES, INC. (US) | 1981-04-29 | — | — | EP | disclosed |
| US-4259232-A | IMMUNOASSAY REAGENTS | MILES LABORATORIES, INC. (US) | 1981-03-31 | — | — | US | disclosed |
| US-4255566-A | N6-(OMEGA-AMINOALKYL)ADENINE DINUCLEOTIDE DERIVATIVES; IMMUNOASSAY | MILES LABORATORIES (US) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263526-A1 | Nitric Oxide Releasing Prodrugs of Therapeutic Agents | NOS2, NOS1, NOS3 | ESR1 1694/4885NR3C1 1961/4885ADRB2 653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.